Telitacicept
- Generic Name
- Telitacicept
- Drug Type
- Biotech
- CAS Number
- 2136630-26-5
- Unique Ingredient Identifier
- 1FHM3D7Z49
Overview
No overview information available.
Background
No background information available.
Indication
用于治疗系统性红斑狼疮（SLE）、类风湿性关节炎等多种自身免疫疾病。 小知识：SLE症状表现多样，如面部出现红斑、关节肿痛、对光过敏、口腔溃疡等，随着病情的进展可导致肾脏、心血管等全身多系统、多器官的不可逆损害，严重威胁生命。目前，我国SLE患病人数超过100万，居全球之首，且多发于15-45岁的年轻女性，女性患病率为男性的10.1倍。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath